Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.59
+0.43 (1.38%)
At close: May 12, 2025, 4:00 PM
31.50
-0.09 (-0.28%)
After-hours: May 12, 2025, 4:39 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $4.08 billion as of May 12, 2025. Its market cap has decreased by -37.86% in one year.
Market Cap
4.08B
Enterprise Value
2.49B
1-Year Change
-37.86%
Ranking
Category
Stock Price
$31.59
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $4.08B, an increase of 195.32%. That is a compound annual growth rate of 24.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.02B | -60.60% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | 1.35B | -1.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |